Following the licensing of rituximab for maintenance therapy NHL and first-line treatment, CSJ explores what this means for the 60,000 patients living with the condition.
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Löwenstein Medical UK Ltd. is a UK subsidiary of Löwenstein Group and represents Löwenstein Medical products. Offering a full range of anaesthesia workstations, neonatal ventilators, ICU-ventilators and sleep diagnostics and therapy devices, including high quality masks for the UK market.
Hilton Birmingham Metropole Hotel
26th - 27th November 2024
Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024
TBA, Leeds
7th December 2024
The National Conference Centre, Birmingham
11th February 2025
Kia Oval, London
11th March 2025, 9:00am - 4:00pm
The National Conference Centre, Birmingham
29th – 30th April 2025
